Effect of Individual Cognitive Stimulation at Home in Adults With Psychotic Disorders
Psychotic Disorders, Schizophrenia, Schizoaffective Disorder
About this trial
This is an interventional treatment trial for Psychotic Disorders focused on measuring cognition, mood, executive functions, quality of life, non-pharmacological therapy, randomised controlled trial, schizophrenia, psychotic disorders, cognitive stimulation
Eligibility Criteria
Inclusion Criteria:
- Adults under 65 years.
- Diagnosed with of schizophrenia spectrum and other psychotic disorders according to the criteria of DSM-5 (APA, 2013), determined by a professional clinician.
- Willing to participate in all intervention and assessment sessions.
- Provided informed consent.
- Native speakers of Portuguese.
Exclusion Criteria:
- Presentation of a condition requiring immediate intervention (e.g., suicidal thoughts).
- Severe sensory and physical limitations that prevent participation in the sessions.
- Severe disconnection with the environment and very limited attentional level.
- Inability to communicate adequately.
- Psychoactive substance use.
- Currently participating in another study.
Sites / Locations
- Cediara - Social Solidarity Association of Ribeira de Fráguas
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Intervention Group
Control Group
Participants who meet the inclusion criteria will be randomly assigned to the intervention group receiving CS or to a control group receiving treatment as usual. Participants in the intervention group will participate in two CS sessions per week for 16 weeks besides their treatment as usual. The sessions will be based on the existing protocol.
Participants assigned to the control group will maintain their usual treatment: social interaction activities, stimulation of personal skills, and any prescribed psychotic-specific medication.